Aramark director granted 101.915 dividend rights

Aramark director Susan M. Cameron received a small stock-based award via dividend equivalents tied to deferred stock units, modestly increasing her direct holdings.

Rhea-AI Filing Summary

Aramark (ARMK) reported that director Susan M. Cameron acquired an additional 101.915 shares of common stock-equivalent through dividend equivalent rights on September 9, 2026. These rights accrued on her deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards, bringing her direct holdings to 48,436.124 shares.

Insider Trade Summary

Grant/Award: 101.915 shares

Grant/Award 1 txn

Insider CAMERON SUSAN M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	101.915	$0.00	$0.00

Holdings After Transaction: Common Stock — 48,436.124 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Key Figures

Shares acquired: 101.915 shares Post-transaction holdings: 48,436.124 shares Reported price per share: $0.0000 +1 more

4 metrics

Shares acquired 101.915 shares Dividend equivalent rights credited on September 9, 2026

Post-transaction holdings 48,436.124 shares Direct common stock-equivalent held by Susan M. Cameron after the grant

Reported price per share $0.0000 Grant of dividend equivalent rights, no cash consideration

Transaction date September 9, 2026 Date dividend equivalent rights were credited

Key Terms

dividend equivalent rights, deferred stock units, quarterly dividend

3 terms

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

deferred stock units financial

"accrued to the reporting person on deferred stock units held by the reporting person"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

quarterly dividend financial

"in connection with the Issuer's quarterly dividend and accrued to the reporting person"

A quarterly dividend is a payment a company gives to its shareholders four times a year, usually as a share of its profits. It's like getting a small bonus every few months for owning the company's stock, which can provide a steady income. Investors watch these payments to see how well a company is doing and whether it’s a good investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Susan M. Cameron?

Aramark reported that director Susan M. Cameron acquired 101.915 shares of common stock-equivalent on September 9, 2026 through a grant of dividend equivalent rights tied to her deferred stock units, with no cash price per share reported.

How many Aramark (ARMK) shares does Susan M. Cameron hold after this Form 4 transaction?

After the reported grant, Susan M. Cameron directly holds 48,436.124 shares of Aramark common stock-equivalent, as disclosed in the Form 4’s post-transaction holdings field.

What are dividend equivalent rights in the Aramark (ARMK) Form 4 for Susan M. Cameron?

The filing states the transaction represents dividend equivalent rights that accrued on Susan M. Cameron’s deferred stock units in connection with Aramark’s quarterly dividend and that these rights vest on the same schedules as the underlying awards.

Was Susan M. Cameron’s Aramark (ARMK) Form 4 transaction under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and the footnote describing the transaction does not reference any Rule 10b5-1 or pre-arranged trading plan.

Did Susan M. Cameron pay a price per share for the Aramark (ARMK) dividend equivalent rights?

No cash consideration is indicated. The Form 4 reports a transaction price per share of $0.0000, consistent with a grant or award of dividend equivalent rights rather than a market purchase.

What type of Form 4 transaction code was used for Susan M. Cameron’s Aramark (ARMK) award?

The transaction uses code A, which the filing describes as a grant, award, or other acquisition of non-derivative common stock, reflecting the credited dividend equivalent rights.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:18 PM Accepted by SEC EDGAR 09/10/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAMERON SUSAN M.

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		A		101.915(1)	A	$0	48,436.124	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)